117 related articles for article (PubMed ID: 7021434)
1. Antitumor activity of intralesionally administered Nocardia opaca preparations in rat and mouse tumors: a comparison with BCG and Corynebacterium parvum.
Barot-Ciorbaru R; Petit JF; Chassoux D; Salomon JC
Int J Immunopharmacol; 1981; 3(2):115-22. PubMed ID: 7021434
[TBL] [Abstract][Full Text] [Related]
2. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of solid tumours by intratumoral injection of immunostimulants].
Salomon JC; Lynch N
Ann Immunol (Paris); 1977; 128(1-2):125-7. PubMed ID: 322574
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of cell-wall skeleton of Propionibacterium acnes C7 in mice and guinea pigs.
Azuma I; Yamawaki M; Yoshimoto T; Saiki I; Uemiya M; Tanio Y; Tokuzen R; Yasumoto K; Yamamura Y
Gan; 1979 Dec; 70(6):737-48. PubMed ID: 395008
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
Tomecki J; Sukiennik J; Kordowiak A
Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
[TBL] [Abstract][Full Text] [Related]
6. Mitogenic activity of the cell walls of mycobacteria, nocardia, corynebacteria and anaerobic coryneforms.
Azuma I; Taniyama T; Sugimura K; Aladin A; Yamamura Y
Jpn J Microbiol; 1976 Aug; 20(4):263-71. PubMed ID: 824484
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
8. Effect of BCG and Corynebacterium Parvum on allograft survival after rabbit antimouse lymphocyte serum and donor bone marrow.
Clark AW; Monaco AP
Surg Forum; 1973; 24():340-3. PubMed ID: 4618660
[No Abstract] [Full Text] [Related]
9. Comparative study on antitumor effect of cell-wall skeleton of Mycobacterium bovis BCG and Nocardia rubra, with reference to T-cell dependency and independency.
Yanagawa E; Yasumoto K; Ohta M; Nomoto K; Azuma I; Yamamura Y
Gan; 1979 Apr; 70(2):141-6. PubMed ID: 381087
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
[TBL] [Abstract][Full Text] [Related]
11. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
Mazureka C; Stiffel C; Chalvet H; Biozzi G
C R Seances Acad Sci III; 1981 Oct; 293(4):225-8. PubMed ID: 6794870
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
Yarkoni E; Rapp HJ
Oncology; 1982; 39(5):314-8. PubMed ID: 7099513
[TBL] [Abstract][Full Text] [Related]
13. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
Lynch NR; Salomon JC
J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
[TBL] [Abstract][Full Text] [Related]
14. The effect of intramural injection of immunotherapeutic agents on bladder histology and systemic humoral response.
Albert NE; Sparks FC; Lytton B
Invest Urol; 1978 Sep; 16(2):134-9. PubMed ID: 361626
[TBL] [Abstract][Full Text] [Related]
15. Proceedings: The effect of Bacille Calmette-Guérin (BCG) and Corynebacterium parvum on the development of spontaneous mouse mammary carcinoma.
Simpson JS; Clark AW
Br J Surg; 1976 Feb; 63(2):152-3. PubMed ID: 766891
[No Abstract] [Full Text] [Related]
16. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
Zbar B; Ribi E; Meyer T; Azuma I; Rapp HJ
J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736
[No Abstract] [Full Text] [Related]
17. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
Scott MT; Milas L
Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
[TBL] [Abstract][Full Text] [Related]
18. Relationship between intradermal tumor suppression and tumor immunity.
Bartlett GL; Kreider JW; Purnell DM
J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of intratumoral injection of bcg and other substances in rats and mice.
Chassoux D; Salomon JC
Int J Cancer; 1975 Oct; 16(4):515-25. PubMed ID: 1176205
[TBL] [Abstract][Full Text] [Related]
20. Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette and Guerin-induced granuloma formation in mice lacking CD4 and CD8.
Senaldi G; Shaklee CL; Mak TW; Ulich TR
Cell Immunol; 1999 May; 193(2):155-61. PubMed ID: 10222057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
